[Possibility to identify fetomaternal haemorrhage].

Ceska Gynekol

Porodnicko-gynekologická klinika FN, Olomouc.

Published: October 2010

Unlabelled: Fetomaternal haemorrhage (FMH) is a status characterised by penetration of fetal blood into the maternal circulation which happens mostly at delivery. FMH may cause erythrocytal alloimmunisation of woman. That is why anti-D immunoglobulin (IgG anti-D) is being administered to RhD negative women after delivery of RhD positive fetus. IgG anti-D is administered to RhD negative women standardly and in much greater quantities than is actually necessary. However, on the other hand, it is not possible to diagnose cases where a greater dose is required. To optimalise prevention of RhD alloimmunization in RhD negative women, it is important to diagnose conditions where fetomaternal haemorrhage (FMH) occurs, precisely define its volume and consequently administer the required dose of IgG anti-D. The ability to reliably detect fetomaternal haemorrhage (FMH) and precisely define its volume would allow better and less expensive prevention of RhD alloimmunization in RhD negative women. IgG anti-D could thus be administered only in cases that are actually indicated and only in doses necessary for preventing RhD alloimmunization. Accurate quantification of FMH is determined by flow cytometry.

Design: Review.

Setting: Department of Obstetrics and Gynecology, Department of Alergology and Clinical Immunology, University Hospital Olomouc.

Download full-text PDF

Source

Publication Analysis

Top Keywords

igg anti-d
16
rhd negative
16
negative women
16
fetomaternal haemorrhage
12
haemorrhage fmh
12
anti-d administered
12
rhd alloimmunization
12
rhd
8
administered rhd
8
prevention rhd
8

Similar Publications

The Coombs test is important in hematology for detecting erythrocyte-bound IgG antibodies or in serm through agglutination methods, but its sensitivity and specificity are limited. Flow cytometry provides a more precise and sensitive alternative for quantitatively assessing RBC-bound IgG antibodies. This assessment is crucial for evaluating the risk of hemolytic reactions and ensuring safe transfusions.

View Article and Find Full Text PDF

Background: Hemolytic disease of the fetus and newborn (HDFN) is a condition due to maternal blood group antibodies targeting antigens in fetal red blood cells, with significant prenatal/perinatal morbidity and mortality. Severe HDFN cases are often associated with alloimmunization against Rhesus D (RhD) or Kell antigens. Information about HDFN epidemiology and treatment in Latin American countries is limited.

View Article and Find Full Text PDF

Colombian consensus for the diagnosis, prevention, and management of Rhesus disease.

Rev Colomb Obstet Ginecol

September 2024

Unidad de Medicina Materno Fetal, Clínica Del Prado, Universidad CES. Medellín (Colombia); Fundared Materna. Bogotá (Colombia).

Article Synopsis
  • Aiming to standardize care for Rh-D negative pregnant women, a panel of 23 experts developed guidelines focused on prevention and management of Rh isoimmunization and related conditions to improve perinatal outcomes.* -
  • Utilizing a modified Delphi method, the panel assessed 22 questions across eight key areas, including Rh-D testing, prenatal care, and treatment strategies for affected fetuses, reaching an 80% consensus on recommendations.* -
  • Key recommendations include encouraging preconception consultations for Rh-D negative women, determining maternal Rh-D status during initial healthcare visits, and ascertaining the father's Rh-D status early in prenatal care.*
View Article and Find Full Text PDF

Naturally Occurring Anti-D in a Male Blood Donor, Unresolved Mystery.

Indian J Hematol Blood Transfus

October 2024

Department of Immunohematology and Blood Transfusion, Medical College, Bharati Vidyapeeth Deemed University, Pune Satara Road, 411043 Dhankawadi, Pune, Maharashtra India.

In accordance with numerous national and international criteria, screening donated blood for abnormal antibodies against red cell antigens is crucial for patient safety. Antibodies can be formed by three mechanisms: by immune responses, naturally occurring, or passively acquired. In accordance with departmental policy, ICT was performed on a 30-yearold male blood donor's sample in addition to ABO Rh grouping.

View Article and Find Full Text PDF

Objective To analyze the serological characteristics and clinical significance of IgG anti-D and anti-C combined antibodies and anti-E and anti-c combined antibodies in patients negative for RhDC and RhEc antigens. Methods The clinical data and laboratory results of 12 cases with two types of irregular antibodies were recorded and analyzed, including age, sex, history of blood transfusion/pregnancy, ABO and RhD blood group identification, Rh antigen typing, irregular antibody screening, antibody-specific identification, absorption-elution tests, antibody titer determination and cross-matching tests. Results Among the 12 patients, the mean age was 51.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!